Literature DB >> 23328160

Prognostic factors including Ki-67 and p53 in Bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancer: a prospective study.

Marco Oderda1, Fulvio Ricceri, Francesca Pisano, Chiara Fiorito, Alberto Gurioli, Giovanni Casetta, Andrea Zitella, Donatella Pacchioni, Paolo Gontero.   

Abstract

OBJECTIVES: To prospectively evaluate the prognostic utility of the traditional prognostic factors and molecular markers p53 and Ki-67 in a homogeneous series of patients with non-muscle-invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guérin (BCG). PATIENTS AND METHODS: 192 intermediate- and high-risk NMIBC cases were enrolled. The variables in study were age, stage, grade, focality, tumour size, presence of associated carcinoma in situ, recurrence rate before BCG, maintenance for BCG, Ki-67 and p53. The endpoints considered were recurrence-free survival, progression-free survival, cancer-specific survival (CSS) and overall survival (OS).
RESULTS: T stage resulted in being associated with CSS, whereas age with OS. BCG maintenance was a significantly favourable independent predictor of OS, CSS, recurrence and progression. In univariate analysis, the labelling index of Ki-67 was significantly associated with OS, CSS and progression. Multivariate analysis, however, confirmed this association only for OS. On the contrary, the labelling index of p53 was a significant predictor of recurrence, both in uni- and multivariate analyses, but with a HR inferior to 1.
CONCLUSIONS: Ki-67 was an independent predictor of survival. p53 overexpression showed a significant yet inverse correlation with recurrence, thus showing little clinical utility. Age, stage and maintenance were confirmed as independent predictors of BCG response.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328160     DOI: 10.1159/000343431

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer.

Authors:  Jianlong Li; Longwang Wang; Ruihai Xiao; Qiufeng Pan; Hongwei Huang; Renrui Kuang
Journal:  Tumour Biol       Date:  2016-01-11

2.  Cripto-1 expression and its prognostic value in human bladder cancer patients.

Authors:  Bingbing Wei; Wei Jin; Jun Ruan; Zhuoqun Xu; You Zhou; Jiabei Liang; Huan Cheng; Ke Jin; Xing Huang; Peng Lu; Qiang Hu
Journal:  Tumour Biol       Date:  2014-10-19

3.  p53 Status correlates with the risk of recurrence in non-muscle invasive bladder cancers treated with Bacillus Calmette-Guérin: a meta-analysis.

Authors:  Xiaofeng Zhou; Guan Zhang; Ye Tian
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

4.  Predicting recurrence and progression of non-muscle-invasive bladder cancer in Korean patients: a comparison of the EORTC and CUETO models.

Authors:  Se Young Choi; Jae Hyung Ryu; In Ho Chang; Tae-Hyoung Kim; Soon Chul Myung; Young Tae Moon; Kyung Do Kim; Jin Wook Kim
Journal:  Korean J Urol       Date:  2014-10-10

Review 5.  High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.

Authors:  Yihuan Luo; Xin Zhang; Meile Mo; Zhong Tan; Lanshan Huang; Hong Zhou; Chunqin Wang; Fanglin Wei; Xiaohui Qiu; Rongquan He; Gang Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

Review 6.  Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yuejun Tian; Zhiming Ma; Zhaohui Chen; Mingguo Li; Zhiping Wu; Mei Hong; Hanzhang Wang; Robert Svatek; Ronald Rodriguez; Zhiping Wang
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

7.  Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review.

Authors:  Yuhui He; Ning Wang; Xiaofeng Zhou; Jianfeng Wang; Zhenshan Ding; Xing Chen; Yisen Deng
Journal:  BMJ Open       Date:  2018-04-17       Impact factor: 2.692

8.  Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.

Authors:  Kyungtae Ko; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.